Skip to content

house · Committee report

H. Rept. 118-765

PROVIDERS AND PAYERS COMPETE ACT

2024-11-22

Committees

Associated legislation

Text

Purpose and Summary

The bill would require that the Secretary of Health and Human Services submit an annual report on the impact of Medicare regulations on provider and payer consolidation.

Background and Need for Legislation

Market consolidation has been linked to less price competition for different providers and payers. Horizontal consolidation, including mergers between providers in the same market, and vertical consolidation among providers, such as hospitals acquiring physician practices, has been shown to lead to higher costs for patients. The share of metropolitan statistical areas analyzed by the Congressional Budget Office (CBO) as being concentrated or highly concentrated increased from 63 percent to 70 percent from 2010-2017. This bill would require an annual report from the Department of Health and Human Services (HHS) to look at the impact of Medicare regulations on consolidation, and would require HHS to evaluate the extent to which the Centers for Medicare and Medicaid Services' (CMS) Innovation Center models impact provider and payer consolidation.

Committee Action

On March 28, 2023, the Subcommittee on Health held a hearing on matters related to the cost of health care and price transparency. The title of the hearing was ``Lowering Unaffordable Costs: Examining Transparency and Competition in Health Care.'' The Subcommittee received testimony from: Chris Severn, Co-Founder & Chief Executive Officer, Turquoise Health; Matthew Forge, Chief Executive Officer, Pullman Regional Hospital; Marilyn Bartlett, Senior Policy Fellow, National Association of State Health Policy; Sophia Tripoli, Director of Health Care Innovation, Families USA; and Benedic Ippolito, Senior Fellow in Economic Policy Studies, American Enterprise Institute. On April 26, 2023, the Subcommittee on Health held a hearing on several pieces of legislation, including a discussion draft titled ``To amend titles XI and XVIII of the Social Security Act to require each outpatient department of a provider to include a unique identification number on claims for services, and to require hospitals with an outpatient department of a provider to submit to the Centers for Medicare & Medicaid Services an attestation with respect to each such outpatient department.'' The title of the hearing was ``Lowering Unaffordable Costs: Legislative Solutions to Increase Transparency and Competition in Health Care.'' The Subcommittee received testimony from: Chiquita Brooks-LaSure, Administrator, Centers for Medicare and Medicaid Services; Ashley Thompson, Senior Vice President, Public Policy Analysis and Development, American Hospital Association; Kristin Bass, Chief Policy and External Affairs Officer, Pharmaceutical Care Management Association; Brian Connell, Executive Director, Federal Affairs, The Leukemia and Lymphoma Society; Sean Cavanaugh, Chief Policy Officer, Aledade, Inc.; Ilyse Schuman, Senior Vice President, Health Policy, American Benefits Council; and Loren Adler, Fellow and Associate Director, USC Brookings Initiative for Health Policy, Economic Studies Program, Brookings Institution. H.R. 3284, the ``Providers and Payers COMPETE Act'' was introduced on May 15, 2023, by Representative Michael C. Burgess (R-TX) and Representative Debbie Dingell (D-MI). H.R. 3284 is based on the discussion draft that the Subcommittee on Health reviewed at its hearing on April 26, 2023. On May 17, 2023, the Subcommittee on Health met in open markup session and forwarded H.R. 3284, without amendment, to the full Committee by a record vote of 27 yeas and 0 nays. On May 24, 2023, the full Committee on Energy and Commerce met in open markup session and ordered H.R. 3284, as amended, favorably reported to the House by a record vote of 49 yeas and 0 nays.

Committee Votes

Clause 3(b) of rule XIII requires the Committee to list the record votes on the motion to report legislation and amendments thereto. The following reflects the record votes taken during the Committee consideration: [GRAPHIC(S) NOT AVAILABLE IN TIFF FORMAT] Oversight Findings and Recommendations Pursuant to clause 2(b)(1) of rule X and clause 3(c)(1) of rule XIII, the Committee held hearings and made findings that are reflected in this report. New Budget Authority, Entitlement Authority, and Tax Expenditures Pursuant to clause 3(c)(2) of rule XIII, the Committee finds that H.R. 3284 would result in no new or increased budget authority, entitlement authority, or tax expenditures or revenues.

Congressional Budget Office Estimate

Pursuant to clause 3(c)(3) of rule XIII, at the time this report was filed, the cost estimate prepared by the Director of the Congressional Budget Office pursuant to section 402 of the Congressional Budget Act of 1974 was not available. Federal Mandates Statement The Committee adopts as its own the estimate of Federal mandates prepared by the Director of the Congressional Budget Office pursuant to section 423 of the Unfunded Mandates Reform Act. Statement of General Performance Goals and Objectives Pursuant to clause 3(c)(4) of rule XIII, the general performance goal or objective of this legislation is to have the Secretary of Health and Human Services submit a report on the impact of Medicare regulations on provider and payer consolidation. Duplication of Federal Programs Pursuant to clause 3(c)(5) of rule XIII, no provision of H.R. 3284 is known to be duplicative of another Federal program, including any program that was included in a report to Congress pursuant to section 21 of Public Law 111-139 or the most recent Catalog of Federal Domestic Assistance. Related Committee and Subcommittee Hearings Pursuant to clause 3(c)(6) of rule XIII, the following related hearings were used to develop or consider H.R. 3284: On March 28, 2023, the Subcommittee on Health held a hearing. The title of the hearing was ``Lowering Unaffordable Costs: Examining Transparency and Competition in Health Care.'' The Subcommittee received testimony from: Chris Severn, Co-Founder & Chief Executive Officer, Turquoise Health; Matthew Forge, Chief Executive Officer, Pullman Regional Hospital; Marilyn Bartlett, Senior Policy Fellow, National Association of State Health Policy; Sophia Tripoli, Director of Health Care Innovation, Families USA; and Benedic Ippolito, Senior Fellow in Economic Policy Studies, American Enterprise Institute. On April 26, 2023, the Subcommittee on Health held a hearing. The title of the hearing was ``Lowering Unaffordable Costs: Legislative Solutions to Increase Transparency and Competition in Health Care.'' The Subcommittee received testimony from: Chiquita Brooks-LaSure, Administrator, Centers for Medicare and Medicaid Services; Ashley Thompson, Senior Vice President, Public Policy Analysis and Development, American Hospital Association; Kristin Bass, Chief Policy and External Affairs Officer, Pharmaceutical Care Management Association; Brian Connell, Executive Director, Federal Affairs, The Leukemia and Lymphoma Society; Sean Cavanaugh, Chief Policy Officer, Aledade, Inc.; Ilyse Schuman, Senior Vice President, Health Policy, American Benefits Council; and Loren Adler, Fellow and Associate Director, USC-Brookings Initiative for Health Policy, Economic Studies Program, Brookings Institution. Committee Cost Estimate Pursuant to clause 3(d)(1) of rule XIII, the Committee adopts as its own the cost estimate prepared by the Director of the Congressional Budget Office pursuant to section 402 of the Congressional Budget Act of 1974. At the time this report was filed, the estimate was not available. Earmark, Limited Tax Benefits, and Limited Tariff Benefits Pursuant to clause 9(e), 9(f), and 9(g) of rule XXI, the Committee finds that H.R. 3284 contains no earmarks, limited tax benefits, or limited tariff benefits. Advisory Committee Statement No advisory committees within the meaning of section 5(b) of the Federal Advisory Committee Act were created by this legislation. Applicability to Legislative Branch The Committee finds that the legislation does not relate to the terms and conditions of employment or access to public services or accommodations within the meaning of section 102(b)(3) of the Congressional Accountability Act. Section-by-Section Analysis of the Legislation Section 1. Short title Section 1 provides that the Act may be cited as the ``Providers and Payers COMPETE Act.'' Section 2. Annual report on the impact of certain medicare regulations on provider and payer consolidation; public comment on provider and payer consolidation for certain proposed rules Section 2 requires that the Secretary of Health and Human Services (HHS) submit an annual report to Congress no later than December 31, 2026, and annually thereafter, on the aggregate impact that certain HHS rules under title XVIII of the Social Security have on provider and payer consolidation. Starting in 2025, the Secretary shall seek public comment on the projected impact that HHS rules will have on provider and payer consolidation as part of its notice and comment rulemaking process. The terms ``provider and payer consolidation'' and ``applicable payment system'' are also defined. Section 3. Consideration of effects on provider and payer consolidation with respect to CMI models Section 3 requires the Secretary to evaluate the extent to which, and how, a Center for Medicare and Medicaid Innovation (CMI) model has affected and could affect provider and payer consolidation. This requirement is effective for models tested on or after January 1, 2025. Changes in Existing Law Made by the Bill, as Reported In compliance with clause 3(e) of rule XIII of the Rules of the House of Representatives, changes in existing law made by the bill, as reported, are shown as follows (existing law proposed to be omitted is enclosed in black brackets, new matter is printed in italics, and existing law in which no change is proposed is shown in roman): SOCIAL SECURITY ACT * * * * * * * TITLE XI--GENERAL PROVISIONS, PEER REVIEW, AND ADMINISTRATIVE SIMPLIFICATION Part A--General Provisions * * * * * * * center for medicare and medicaid innovation Sec. 1115A. (a) Center for Medicare and Medicaid Innovation Established.-- (1) In general.--There is created within the Centers for Medicare & Medicaid Services a Center for Medicare and Medicaid Innovation (in this section referred to as the ``CMI'') to carry out the duties described in this section. The purpose of the CMI is to test innovative payment and service delivery models to reduce program expenditures under the applicable titles while preserving or enhancing the quality of care furnished to individuals under such titles. In selecting such models, the Secretary shall give preference to models that also improve the coordination, quality, and efficiency of health care services furnished to applicable individuals defined in paragraph (4)(A). (2) Deadline.--The Secretary shall ensure that the CMI is carrying out the duties described in this section by not later than January 1, 2011. (3) Consultation.--In carrying out the duties under this section, the CMI shall consult representatives of relevant Federal agencies, and clinical and analytical experts with expertise in medicine and health care management. The CMI shall use open door forums or other mechanisms to seek input from interested parties. (4) Definitions.--In this section: (A) Applicable individual.--The term ``applicable individual'' means-- (i) an individual who is entitled to, or enrolled for, benefits under part A of title XVIII or enrolled for benefits under part B of such title; (ii) an individual who is eligible for medical assistance under title XIX, under a State plan or waiver; or (iii) an individual who meets the criteria of both clauses (i) and (ii). (B) Applicable title.--The term ``applicable title'' means title XVIII, title XIX, or both. (5) Testing within certain geographic areas.--For purposes of testing payment and service delivery models under this section, the Secretary may elect to limit testing of a model to certain geographic areas. (b) Testing of Models (Phase I).-- (1) In general.--The CMI shall test payment and service delivery models in accordance with selection criteria under paragraph (2) to determine the effect of applying such models under the applicable title (as defined in subsection (a)(4)(B)) on program expenditures under such titles and the quality of care received by individuals receiving benefits under such title. (2) Selection of models to be tested.-- (A) In general.--The Secretary shall select models to be tested from models where the Secretary determines that there is evidence that the model addresses a defined population for which there are deficits in care leading to poor clinical outcomes or potentially avoidable expenditures. The Secretary shall focus on models expected to reduce program costs under the applicable title while preserving or enhancing the quality of care received by individuals receiving benefits under such title. The models selected under this subparagraph may include, but are not limited to, the models described in subparagraph (B). (B) Opportunities.--The models described in this subparagraph are the following models: (i) Promoting broad payment and practice reform in primary care, including patient-centered medical home models for high-need applicable individuals, medical homes that address women's unique health care needs, and models that transition primary care practices away from fee-for-service based reimbursement and toward comprehensive payment or salary-based payment. (ii) Contracting directly with groups of providers of services and suppliers to promote innovative care delivery models, such as through risk-based comprehensive payment or salary-based payment. (iii) Utilizing geriatric assessments and comprehensive care plans to coordinate the care (including through interdisciplinary teams) of applicable individuals with multiple chronic conditions and at least one of the following: (I) An inability to perform 2 or more activities of daily living. (II) Cognitive impairment, including dementia. (iv) Promote care coordination between providers of services and suppliers that transition health care providers away from fee-for-service based reimbursement and toward salary- based payment. (v) Supporting care coordination for chronically-ill applicable individuals at high risk of hospitalization through a health information technology-enabled provider network that includes care coordinators, a chronic disease registry, and home tele-health technology. (vi) Varying payment to physicians who order advanced diagnostic imaging services (as defined in section 1834(e)(1)(B)) according to the physician's adherence to appropriateness criteria for the ordering of such services, as determined in consultation with physician specialty groups and other relevant stakeholders. (vii) Utilizing medication therapy management services, such as those described in section 935 of the Public Health Service Act. (viii) Establishing community-based health teams to support small-practice medical homes by assisting the primary care practitioner in chronic care management, including patient self- management, activities. (ix) Assisting applicable individuals in making informed health care choices by paying providers of services and suppliers for using patient decision- support tools, including tools that meet the standards developed and identified under section 936(c)(2)(A) of the Public Health Service Act, that improve applicable individual and caregiver understanding of medical treatment options. (x) Allowing States to test and evaluate fully integrating care for dual eligible individuals in the State, including the management and oversight of all funds under the applicable titles with respect to such individuals. (xi) Allowing States to test and evaluate systems of all-payer payment reform for the medical care of residents of the State, including dual eligible individuals. (xii) Aligning nationally recognized, evidence-based guidelines of cancer care with payment incentives under title XVIII in the areas of treatment planning and follow-up care planning for applicable individuals described in clause (i) or (iii) of subsection (a)(4)(A) with cancer, including the identification of gaps in applicable quality measures. (xiii) Improving post-acute care through continuing care hospitals that offer inpatient rehabilitation, long- term care hospitals, and home health or skilled nursing care during an inpatient stay and the 30 days immediately following discharge. (xiv) Funding home health providers who offer chronic care management services to applicable individuals in cooperation with interdisciplinary teams. (xv) Promoting improved quality and reduced cost by developing a collaborative of high-quality, low-cost health care institutions that is responsible for-- (I) developing, documenting, and disseminating best practices and proven care methods; (II) implementing such best practices and proven care methods within such institutions to demonstrate further improvements in quality and efficiency; and (III) providing assistance to other health care institutions on how best to employ such best practices and proven care methods to improve health care quality and lower costs. (xvi) Facilitate inpatient care, including intensive care, of hospitalized applicable individuals at their local hospital through the use of electronic monitoring by specialists, including intensivists and critical care specialists, based at integrated health systems. (xvii) Promoting greater efficiencies and timely access to outpatient services (such as outpatient physical therapy services) through models that do not require a physician or other health professional to refer the service or be involved in establishing the plan of care for the service, when such service is furnished by a health professional who has the authority to furnish the service under existing State law. (xviii) Establishing comprehensive payments to Healthcare Innovation Zones, consisting of groups of providers that include a teaching hospital, physicians, and other clinical entities, that, through their structure, operations, and joint- activity deliver a full s

Source: https://api.congress.gov/v3/committee-report/118/hrpt/765